HCA Healthcare Surges to 109th in Trading Volume with $774 Million Turnover

On April 24, 2025, HCA Healthcare (HCA) saw a significant increase in trading volume, with a turnover of $774 million, marking a 64.51% rise from the previous day. This surge placed HCA at the 109th position in terms of trading volume for the day. The stock price of HCA rose by 1.62%, marking the third consecutive day of gains, with a total increase of 7.49% over the past three days.

HCA Healthcare is scheduled to release its first-quarter earnings results on April 25, 2025, before the market opens. Analysts anticipate the company to report earnings per share (EPS) of $5.75, reflecting a 3.0% year-over-year decrease. In the previous quarter, HCA Healthcare exceeded analysts' revenue expectations by 0.7%, reporting revenues of $18.29 billion, a 5.7% year-over-year increase. However, the quarter was mixed, with a narrow beat of analysts' EPS estimates but same-store sales in line with expectations.

For the upcoming quarter, analysts project HCA Healthcare's revenue to grow by 5.1% year over year to $18.23 billion, a slowdown from the 11.2% increase recorded in the same quarter last year. Adjusted earnings are expected to be $5.75 per share. HCA Healthcare has a strong track record of meeting or exceeding revenue estimates, having only missed once in the last two years and exceeding top-line expectations by an average of 2.1%.

HCA Healthcare's peers in the healthcare providers and services segment have shown mixed results. Elevance Health reported year-on-year revenue growth of 14.8%, beating analysts' expectations by 5.3%, while Quest reported revenues up 12.1%, topping estimates by 1.3%. Despite these positive results, the healthcare providers and services group has generally underperformed, with share prices down 7.7% on average over the last month. HCA Healthcare's stock price remained unchanged during this period.